Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation

Peter MA Calverley1 Department of Medicine, Clinical Sciences Centre, University Hospital Aintree, Liverpool, UKCorrespondence[email protected]

Clive Page2 Faculty of Life Sciences and Medicine, King’s College, London, UK

Roberto W Dal Negro3 Lung Unit, National Centre for Respiratory Pharmacoeconomics and Pharmacoepidemiology, Verona, Italy

Giovanni Fontana4 Pulmonology Department, Cough Centre, Careggi University Hospital, Firenze, Italy

Mario Cazzola5 Department of Systems Medicine, Chair of Respiratory Medicine, University of Rome ‘Tor Vergata’, Rome, Italy

Arrigo F Cicero6 Medical and Surgical Department, University of Bologna, Bologna, Italy

Edoardo Pozzi7 Medical Affairs Department, Edmond Pharma, Paderno, Italy

Jadwiga A Wedzicha8 Respiratory Division, National Heart And Lung Institute, Imperial College London, London, UK

Your download is now in progress and you may close this window